Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care
Patient-based record reported to improve quality, safety and efficiency.
MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), yesterday announced that NYCLIX is now sharing key patient data electronically among ten unaffiliated healthcare organizations across New York City using the company's Centergy(TM) suite of integrated health information exchange (HIE) solutions. NYCLIX partner hospitals and physicians now have the opportunity to enhance the quality, safety and efficiency of patient care by accessing in real time clinical information using a patient-based record that is accessible through interoperable hospital network and Electronic Health Record (EHR) technologies.
NYCLIX partner healthcare institutions record 840,000 emergency visits annually, as well as 470,000 discharges, 6.8 million outpatient visits and 5.9 million home visits. NYCLIX's vision is a healthcare system that facilitates patients' access to care; improves quality, safety and efficiency; and empowers consumers through improved access to information, all while preserving patient privacy.